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Abstract
Norovirus infections are notoriously difﬁcult to prevent and control, owing to their low infectious dose, high shedding titre, and
environmental stability. The virus can spread through multiple transmission routes, of which person-to-person and foodborne are the most
important. Recent advances in molecular diagnostics have helped to establish norovirus as the most common cause of sporadic
gastroenteritis and the most common cause of outbreaks of acute gastroenteritis across all ages. In this article, we review the epidemiology
and virology of noroviruses, and prevention and control guidelines, with a focus on the principles of disinfection and decontamination.
Outbreak management relies on sound infection control principles, including hand hygiene, limiting exposure to infectious individuals, and
thorough environmental decontamination. Ideally, all infection control recommendations would rely on empirical evidence, but a number of
challenges, including the inability to culture noroviruses in the laboratory and the challenges of outbreak management in complex
environments, has made it difﬁcult to garner clear evidence of efﬁcacy in certain areas of infection control. New experimental data on
cultivable surrogates for human norovirus and on environmental survivability and relative resistance to commonly used disinfectants are
providing new insights for further reﬁnining disinfection practices. Finally, clinical trials are underway to evaluate the efﬁcacy of vaccines,
which may shift the current infection control principles to more targeted interventions.
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Introduction
Norovirus is a leading cause of acute gastroenteritis in people
of all ages and settings. Approximately 19–21 million norovirus
illnesses occur each year in the USA [1]. A high titre of
shedding by infected persons, a low infectious dose and
environmental stability are some of the attributes that facilitate
effective norovirus transmission through a variety of modes
(person-to-person, food, water, and environment) [2–5].
These attributes present an array of challenges for prevention
and control, in particular in institutional settings [4,6].
Specialists involved with infection and environmental control
use a range of strategies aimed at preventing and controlling
norovirus outbreaks [7–9]. However, some of these measures,
such as ward/unit closures in hospitals, can place a substantial
burden on institutions and personnel; a UK study estimated a
loss of c. $1 million for every 1000 beds [10–12]. Ideally,
outbreak management guidelines would be supported by
high-quality empirical evidence. However, generating high-
quality evidence for efﬁcacy is difﬁcult, as the evidence for
outbreak management is largely empirical, and there are
challenges associated with a non-cultivable virus. Here, we
review the current knowledge of norovirus outbreak epide-
miology and virology, and infection control guidelines, with a
focus on disinfection and decontamination, and highlight areas
for future research.
Norovirus Outbreaks
Settings
Outbreaks provide an opportunity to study norovirus epide-
miology, including how these viruses spread and what control
measures are effective. Outbreaks occur in the diverse range of
settings where humans congregate. In the USA, outbreaks in
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restaurants and on cruise ships are frequently picked up by the
media. However, one would have a skewed sense of the
distribution of norovirus outbreak patterns from media reports
alone. Data from broad-based surveillance in high-
income countries show that the majority of outbreaks occur
in healthcare facilities; however, the speciﬁc types of facility
reporting outbreaks can differ between countries. In the USA,
>60% of all norovirus outbreaks occur in long-term-care
facilities [13,14]. This contrasts with the settings reported in
Europe, Japan, and other high-income settings, where out-
breaks in acute-care hospitals are common and roughly equal in
number to outbreaks in long-term-care facilities (Fig. 1) [15]. In
the USA, acute-care outbreaks are relatively uncommon,
constituting c. 5% of norovirus outbreaks [13,16]. Whether
the lower frequency of outbreaks reported from US hospitals
represents a real difference in epidemiology or infection
control, or an artefact of reporting bias, is not well understood.
Modes of transmission
Although noroviruses have been detected in bovines, mice, and
canines, these virus strains appear to be highly species-speciﬁc,
and zoonotic transmission does not seem be common. In
humans, the virus typically spreads directly via person-to-person
transmission (faecal–oral and vomit–oral) or indirectly through
foodborne, waterborne and environmental transmission. Direct
person-to-person transmission is reported in >90% of the
norovirus outbreaks in healthcare facilities [6,13,17]. Food-
borne, waterborne and environmental transmission have some
features in common, in the sense that a food product, water
source or fomite may become contaminated by an infected
person, and another individual then ingests virus after coming
into contact with that object. In the USA, norovirus is estimated
to be the most common aetiological cause of foodborne illness,
which accounts for 7–24% of norovirus outbreaks worldwide
[13,14,18–20]. Although food may become contaminated at any
point in the ‘farm to fork continuum’, the majority of foodborne
norovirus illness is a result of contamination by infected
food-handlers during preparation [21]. Ready-to-eat foods (such
as leafy greens) and foods handled after cooking are the most
frequently identiﬁed products associated with outbreaks [21].
Each of these transmission modes presents speciﬁc challenges in
terms of infection prevention and control, as discussed below.
The high levels of virus shed in faeces and vomit [2], the low
infectious dose [3] and the environmental stability of the virus
[4] all contribute to the ability of noroviruses to utilize various
modes of transmission (Table 1). Furthermore, transmission
has been reported to occur before the onset of symptoms
[22], in the post-symptomatic period, and during subclinical
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FIG. 1. Setting of (a) norovirus outbreaks reported in ﬁve European
countries with broad-based surveillance, 2002, n = 1115, and (b) the
USA, 2009–2013, n = 2895. Long Term Care Facility (LTCF). Adapted
from Lopman et al. [15] and Vega et al. [13].
TABLE 1. Characteristics that facilitate norovirus transmis-
sion
Characteristics Description
Low infectious dose Estimates of the infectious dose ranges
from 18 to 103 virus particles [3]
High shedding titre Peak shedding ranges from 105 to 109
particles/g of stool [2]
Prolonged shedding Virus can be detected up to 8 weeks after
symptom onset, with a median
of 4 weeks; even longer durations of
shedding may be detected in
immunocompromised individuals [2,107]
Genetic diversity Over 30 genotypes (nine GI and 22 GII)
infect humans [5].
No long-lasting immunity [25,108].
Different genotypes can infect humans
over their lifetime [25]
Environmental stability Norovirus particles may be infectious for
2 weeks on environmental surfaces and for
>2 months in water [67,109]
Resistant to common
disinfectants
Surrogates used to determine the efﬁcacy of
EPA-registered disinfectant products have
different physiochemical properties;
therefore, different disinfection proﬁles
exist, and overestimate the efﬁcacy of
disinfectant products [29,87]
Vomiting Vomiting appears to be a particularly effective
route of norovirus spread. Vomiting events
may occur and lead to direct transmission
(when in public) as well as environmental
contamination from vomit droplets
[59,110]
Transmission through
multiple routes
Noroviruses are transmitted via the
faecal–oral route and vomit–oral route,
and through a number of speciﬁc modes,
including foodborne, waterborne,
environmental and direct person-to-
person spread [6,13,21,57,64]
Adapted from [4].
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infections [23]. However, the currently available evidence
suggests that individuals are less infectious when they are
asymptomatic, and that vomiting [23] is strongly associated
with transmission [24].
Importance of genotyping noroviruses for understanding
transmission
Noroviruses are a group of genetically diverse single-stranded
RNA viruses. There are six known genogroups (G), two of
which (I and II) commonly cause human disease, and can be
further subdivided into nine and 22 genotypes, respectively [5].
Immunity appears to be largely restricted to homotypic
genogroups or genotypes [25]. This genetic diversity has
public health relevance, in that certain genotypes are associ-
ated with different modes of transmission and, perhaps,
severity of disease outcomes. Genogroup I viruses are more
often associated with food and waterborne outbreaks (Fig. 2).
For example, the recently emerged GI.6 virus is more often
associated with foodborne disease [26]. Conversely, GII.4
viruses are strongly associated with person-to-person trans-
mission and healthcare settings [27]. Factors that may promote
GII.4 transmission in closed settings include a possibly longer
duration of shedding [25], more frequent vomiting [28], and
different environmental survival and disinfection resistance
proﬁles [29,30]. Moreover, GII.4 infections are likely to be of
greater severity and result in more hospitalizations and deaths
than those caused by other GII or GI viruses, even after
accounting for the different case mix of the populations
affected by the different viruses (that is, GII.4 viruses primarily
cause outbreaks among the elderly in institutionalized health-
care settings) [31].
Current Guidelines and the Evidence Base
for their Efﬁcacy
Outbreak management
Healthcare institutions provide services to vulnerable popula-
tions,andarethemostcommonsettings fornorovirusoutbreaks.
For these reasons, these settings will constitute the focus of our
discussions on infection control issues, but most of these
principles also apply to other settings. Outbreak management is
amultistage process: preparedness, identiﬁcation, response, and
evaluation [32]. An institutional structure conducive to organiz-
ing and timing the actions to prevent and control infection
facilitates the containment of outbreaks [33]. The ability to
identify a norovirus outbreak as early as possible is a key aspect in
initiating infection control measures [8]. Although outbreak
controlmeasures arebasedonsound infectioncontrol principles
[8,34], there are scant data to demonstrate that implementing
speciﬁc infection control measures decrease the magnitude or
durationofnorovirusoutbreaks[35].Evaluatingtheeffectiveness
0
500
1000
1500
Person to
person
Other/
unknown
Foodborne
Genotype
GI
GII non-4
GII.4
Genotype by mode(a)
0
500
1000
1500
Healthcare Other
settings
Restaurants
and
events
Genotype
GI
GII non-4
GII.4
Genotype by setting(b)
0
500
1000
1500
Healthcare Other
settings
Restaurants
and
events
Mode
Person to
person
Other/
unknown
Foodborne
Mode by setting(c)
FIG. 2. Distribution of norovirus genotype (GI, GII.4, GII non-4) by mode of transmission (a) and by outbreak setting (b), as well as mode of
transmission by outbreak setting (c), from 2895 norovirus outbreaks reported to CaliciNet, 2009–2013. Adapted from Vega et al. [13].
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of infection control measures for norovirus outbreaks is an
important part of the process for developing evidence-based
guidelines [7,35,36], but there areethical and scientiﬁc challenges
to conducting such studies [37].
Guidelines for managing norovirus outbreaks have been
issued by public health agencies in several countries, including
Australia, Ireland, the UK, and the USA [7,8,36,38,39]. Some
guidelines, such as those from the UK and the USA, used
systematic literature reviews followed by grading the strength
of recommendations. Guidelines from other countries based
their recommendations on a more expert opinion-driven
approach to assessing evidence. Regardless of the methods
used, recent guidelines are generally consistent in the
measures that they recommend. The main approaches to
preventing and containing norovirus outbreaks that are
common across several guidelines include implementing pol-
icies concerning hand hygiene, patient isolation (separation of
symptomatic patients) and cohorting (grouping of patients
based on symptoms), staff exclusion from work, visitor
restrictions, enhanced environmental cleaning and disinfection,
and ward closures (Table 2) [7,8,33,36,38,39].
Hygiene
A diverse set of recommendations for the prevention and
control of norovirus outbreaks are needed, given the various
transmission modes by which norovirus spreads and the lack of
a ‘magic bullet’ to curtail transmission. In general, hand hygiene
adherence should be actively promoted among healthcare
personnel, patients and visitors in patient-care areas affected by
outbreaks of norovirus gastroenteritis. During outbreaks,
hands should be washed with soap and running water for a
minimum of 20 s after providing care for patients with
suspected or conﬁrmed infection [7,8]. Data from several
studies suggest that this method of hand hygiene is an effective
intervention for reducing norovirus risk [7,40–42]. Despite
widespread use, there is inconclusive evidence for the effec-
tiveness of alcohol-based hand sanitizers for norovirus [29,43–
45]. Therefore, during outbreaks, they should be used as an
adjunct to hand-washing [8]. Aerosolization of noroviruses and
close, direct contact with an infected individual contribute to
the high risk of transmission [46]. Therefore, the use of
appropriate personal protective equipment, i.e. gloves and
masks, especially when cleaning up vomit, is another measure
for limiting the further spread of norovirus infection to staff in
healthcare facilities [7]. During an outbreak, personal protec-
tive equipment should be disposable and single-use [7,39].
Cleaning and disinfection
Enhanced cleaning and disinfection protocols may control and
prevent the spread of norovirus [47–49]. This includes increas-
ing the frequency of cleaning and paying closer attention to
high-trafﬁc areas and frequently touched surfaces, including, for
example, door handles and telephones [4,7,8]. For disinfection, a
bleach solution at a minimum concentration of 1000 p.p.m.
sodium hypochlorite prepared fresh daily is recommended [8].
The results from several studies have demonstrated that bleach
effectively disinfects norovirus better than other products, i.e.
quaternary ammonium-based products [50–53]. In areas where
bleach is not available or is corrosive to materials, EPA-regis-
tered products, in particular List G, are available that can be
effective against norovirus surrogates [54]. Cleaning and disin-
fection should proceed from unaffected areas to affected areas,
with care being taken to clean from low-contamination areas to
high-contamination areas [36]. Steamcleaning can be considered
for soft furnishings, i.e. rugs, carpets, chairs, and other fabrics,
that are adversely affected by bleach [7,36].
Isolation and cohorting
Isolation, cohorting (grouping of patients on the basis of
symptoms) and exclusion of symptomatic staff, patients and
visitors constitute another class of recommended strategies
for infection control [7,8,33,36,38,39]. These strategies can
prevent the amount of secondary transmission, and decrease
the outbreak duration [55–59]. Although most guidelines
recommend cohorting patients into groups on the basis of
symptomatic, exposed asymptomatic and unexposed asymp-
tomatic status [7,8,33,36,38,39], at a minimum, symptomatic
patients should be isolated in a single ward or care unit in
order to minimize secondary transmission [39]. Several
guidelines stress that symptomatic patients should not be
transferred to other wards/units within the facility or between
facilities until at least 48 h after symptoms have been resolved,
in order to reduce the spread of infection to unaffected areas
or facilities [7,8,33,36,38]. To minimize the spread of norovirus
between patient cohorts, healthcare institution staff should
care for one patient cohort at a time, and movement of staff
between patient cohorts should be lmited. In particular, staff
assigned to symptomatic patients should strictly adhere to all
enhanced infection control policies [7]. Exclusion of staff
members from work during illness and for at least 48 h after
resolution of symptoms can reduce transmission to patients
during the symptomatic and post-symptomatic phases of
infection [60]. Sick pay and sick leave policies in healthcare
institutions that do not penalize ill workers may help to
prevent staff from working while infectious [8] but these
measures may also lead to unintended consequences, such as
staff shortages [11,61]. Minimizing access of visitors and
non-essential personnel to affected areas and the exclusion
of symptomatic visitors is strongly recommended. As visitors
may not be knowledgeable about norovirus, facilities can
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provide educational material describing the risks of norovirus
transmission and measures to prevent infection [7,33,39].
Finally, and perhaps most controversially, some guidelines
recommend closing units, or parts thereof, to new admissions
or transfers [7,8,33,36,38,39]. Most data suggest that ward
closure is effective in terms of reducing the number of cases
and the duration of outbreaks [12,46,62].
Organizational structure and response
A common theme in several national guidelines is the value of
an organizational structure within a healthcare institution that
is capable of providing timely response to outbreaks
[36,38,39]. One department that is accountable for identifying
and implementing recommendations can streamline the initi-
ation of protocols and infection control measures [63]. The
reporting of norovirus outbreaks from healthcare institutions
to appropriate public health authorities may assist in outbreak
control and, ultimately, through collection of surveillance data,
provide evidence supporting speciﬁc actions [7,8,33,36,38,39].
Food-handling
Foodborne outbreaks arise from a variety of contamination
points, i.e. during production, processing, preparation, or
service. Infected food-handlers contaminating ready-to-eat food
is the most common source of foodborne norovirus outbreaks
[21]. Leafy vegetables, fruits, and shellﬁsh, all of which are
commonly consumed raw or undercooked, are the food
commodities most commonly reported as the cause of food-
borne norovirus outbreaks [21,64]. Determining whether food
is the cause of the outbreak as early as possible can facilitate the
withdrawal of implicated food or the exclusion of infected
food-handlers, hence limiting both primary food exposures and
the secondary spread of norovirus infection [21,64]. Contam-
inated food and exposed utensils should be removed and
appropriately disinfected, as should contaminated common
areas such as dining halls [8,9,39]. Like healthcare workers,
food-handlers should remain off work for at least 48 h after
symptom resolution [65,66]. Ensuring that staff involved in food
preparation, storage and serving adhere to theUSFoodandDrug
Administration FoodCode is important in preventing foodborne
norovirus outbreaks [8,9,34]. Two key infection control mea-
sures speciﬁc to food-service settings include eliminating bare--
handed contact with ready-to-eat foods and the presence of
certiﬁed kitchen managers with food safety training [9].
Implications of Environmental Stability of
Human Norovirus
The infectiousness of norovirus outside the human host is
inﬂuenced by intrinsic characteristics of the virus, such as
physiochemical properties (thermal and desiccation resistance)
and extrinsic characteristics (surface types). Norwalk virus
seeded into ground water for at least 61 days was still able to
infect human volunteers [67]. Although human noroviruses
cannot yet be cultured in vitro [68], cultivable viruses, i.e.
coliphage MS2 (MS2), murine norovirus (MNV), and feline
calicivirus (FCV), have been used widely to assess the use of
TABLE 2. Summary of infection control guidelines for the
prevention and management of norovirus outbreaks in
healthcare settings
Infection control
category Infection control strategy
Outbreak
identiﬁcation
Deﬁne start of outbreak: enables the initiation of
enhanced norovirus infection control measures
Two or more associated patients with gastroenteritis
onsets within 24–48 h of each other
Use Kaplan’s clinical and epidemiological criteria to
identify norovirus outbreak, if clinical laboratory
testing is not available
Stool negative for bacteria
Mean duration of illness of 12–60 h
Vomiting in >50% of cases
Incubation period of 24–48 h
Hygiene Wash hands with soap and warm running water for a
minimum of 20 s before and after contact with
patients, after using the lavatory, and/or before
and after eating
Wear appropriate personal protective equipment
(PPE)
Gloves: if directly contacting symptomatic patients
Masks: if a potential risk of aerosolization, e.g.
vomit, exists
Gowns: if a potential risk of splashing exists
Goggles/face shields: if a potential risk of splashing
exists
Change PPE frequently
Cleaning and
disinfection
Increase the frequency of cleaning and disinfection of
high-trafﬁc areas and implicated areas
Clean and disinfect from unaffected to affected areas
Clean areas of any organic material
Disinfect all surfaces with freshly prepared 0.1%
(1000 p.p.m.) sodium hypochlorite (bleach)
Clean carpets with detergent and warm water, and
follow this with steam cleaning
Steam-clean all soft furnishings that may be damaged
by bleach
Discard all disposable cloths in biohazard bags
Launder all non-disposable cloths, i.e. linens,
blankets, towels, and clothing
Patient isolation/
cohorting and
transfer
Separate patients on the basis of symptomatic,
exposed asymptomatic, or unexposed asymptomatic
Limit movement and transfer of symptomatic
patients
Staff exclusion
and cohorting
Exclude ill staff for at least 48 h after symptom
resolution
Assign staff to one patient cohort
Visitors Limit visits to implicated wards
Limit symptomatic visitors until 48 h after symptom
resolution
Provide educational material that describes the risks
of norovirus transmission and measures to prevent
infection
Ward closures Consider closing the unit or ward to new admissions
and transfers
Outbreak reporting Notify appropriate local or state health
departments, as per local and state public health
regulations
Food safety Discard exposed food
Exclude ill staff for at least 48 h after symptom
resolution
Close communal dining areas
Ensure proper food preparation, storage, and
serving
Eliminate bare-handed contact with ready-to-eat
foods
Adapted from [7], [8], [36], and [39].
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physiochemical abilities to predict the infectivity of human
norovirus [69–71]. Such surrogate-based studies have esti-
mated that human norovirus could stay potentially infectious
on frozen foods (less than or equal to20°C), refrigerated
foods (≤10°C) and fomites for up to 6 months [72,73], up to
7 days [74,75], and ≥7 days [76], respectively. Robust stability
(<1 log10 of infectivity loss for 1 h of contact) of virus on
hands was also demonstrated in an in vivo study with FCV and
MNV [77]. Additionally, norovirus can be easily transferred
between hands and surfaces through casual contact, which
probably contributes to the spread of norovirus in the
community [3,78,79].
Further considerations on norovirus interventions
The basis for recommending washing of hands with soap is that
soap, in several in vivo experiments, has been demonstrated to
be more effective in removing viruses from hands than topical
agents (e.g. alcohol-based hand sanitizers) [41,45]. However,
few data are available on the level and frequency of contamina-
tion on hands from infected individuals, and it therefore remains
uncertainwhether hand-washing alone is sufﬁcient to reduce the
risk [80]. Also, hand-washing compliance is a general issue, with
implications for a range of healthcare-associated pathogens, and
not only norovirus. Alcohol-based hand sanitizers may be used
as an adjunct but not as a substitute for hand-washing during
norovirus outbreaks [7,81]. A number of studies have supported
the virucidal activity of alcohol-based hand sanitizers against
human norovirus and multiple surrogates [29,43,52,77]; other
active ingredients (e.g. benzalkonium chlorite (Quat), triclosan,
or chlorhexidine) were ineffective [29]. However, the clinical
value (i.e. effectiveness) of alcohol-based sanitizers is a function
of both: (i) their ability to inactivate viruses (i.e. efﬁcacy), which
depends both on the formulation and on the way they are tested
in vitro or in vivo [29,41,77,82,83]; and (ii) compliance, which
includes both the frequency of use and proper application [34].
Overall, the lack of data on real-world effectiveness makes it
difﬁcult to generalize claims simply based on in vitro or in vivo
experiments on a particular formulation. More comprehensive
studies are warranted.
There is little information on the bio-burden of norovirus
on hard surfaces, but recent data have shown that the surfaces
of a few high-contact objects (i.e. doorknobs, toilet seats, and
faucets) can be contaminated with up to 104 virus particles per
object (unpublished data), which strongly suggests that reduc-
tions in levels of 3–4 log10 are required to eliminate norovirus
contamination on high-contact surfaces [7,8]. The use of
sodium hypochlorite solution (≥1000 p.p.m.) remains reliable
for achieving a higher than 3 log10 reduction of human
norovirus on surfaces, but pre-cleaning before its application
is strongly recommended, to reduce the faecal organic load
[7,8,48]. EPA-registered products claimed to have efﬁcacy
against human norovirus (e.g. List G) can be considered as
alternative options. However, care should be taken, as FCV,
which is ofﬁcially used for claims of efﬁcacy against human
norovirus in EPA-registered products [54], is not the most
resistant surrogate virus for predicting inactivation of human
norovirus [29,71,86,87]. However, some recent EPA-
registered products, which claimed norovirus antiviral activity,
provided additional efﬁcacy information against other nor-
ovirus surrogate viruses, such as MNV. The utilization of
multiple norovirus surrogates demonstrating efﬁcacy against
norovirus can allow for a more conservative selection of
appropriate disinfectants. In addition, the EPA test protocol
allows for a longer duration of contact between disinfectant
and inoculum (usually ≥5 min), whereas a shorter exposure
time (1–3 min or shorter) is the practice more likely to be
used in the ﬁeld, potentially reducing the efﬁcacy of these
disinfectants [84,85]. Thus, strict compliance with the manu-
facturer’s instructions is strongly advised to achieve the
claimed efﬁcacy.
Contaminated hands and surfaces may both contribute to
norovirus transmission via regular interactions between hands
and their surroundings, and hand and surface interventions
should therefore complement each other. It is important to
note the limitations of these traditional hygiene interventions.
In particular, if sufﬁcient decontamination is achieved, surfaces
in areas of high contamination risk (e.g. toilets) are susceptible
to recontamination by contact with affected or asymptomatic
carriers. However, the effects of surface disinfection or
hand-washing are transient, because commercial chemical
disinfectants do not have any residual antimicrobial activity
[4]. In addition to having proven effectiveness against norovi-
rus, chemical disinfectants must also satisfy other require-
ments, such as low toxicity for personnel, and a low risk of
damaging contaminated surface materials [88]. Novel disinfec-
tion methods are being considered as alternatives or comple-
ments to traditional hygiene interventions, but further
research is needed (Table 3) [89–94].
Future Research
Advances in disinfection technology for environmental and
food safety use may direct updated guidelines for infection
control practices [95,96]. A successful technology, such as high
hydrostatic pressure, may have the potential for use in food
safety [97–100]. Short of developing a norovirus cell culture
system, norovirus surrogates such as Tulane virus, porcine
enteric calicivirus, MNV and FCV may help in better assess-
ment of the efﬁcacy of cleaning and disinfection practices
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[98,100]. Future studies should be directed towards quantita-
tive assessment of norovirus contamination at each stage of
the infection transmission cycle. Carefully designed observa-
tional studies or, preferably, intervention trials may help to
answer the question of whether cohorting and/or unit closures
alone or in conjunction with other strategies, i.e. cleaning and
disinfection, are effective at controlling norovirus outbreaks.
Progress is also being made in the development of a norovirus
vaccine [101–105]. Accordingly, there are a number of
possible strategies (e.g. vaccinating healthcare workers or
nursing home residents) that will require careful evaluation.
None of these developments in infection prevention will
happen in isolation, so the costs and beneﬁts of both individual
interventions and combinations should be assessed [10,106].
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